Alameda, CA, United States of America

Susan L Hammond

This inventor holds 2 USPTO granted patents. Top assignees: Chiron Diagnostics Corporation, Ciba Corning Diagnostics Corp.. Active years: 1994-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan L Hammond. Retrieved from https://idiyas.com/inventor/susan-l-hammond

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1994-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Susan L Hammond: Innovator in Cancer Detection

Introduction

Susan L Hammond is a notable inventor based in Alameda, CA (US). She has made significant contributions to the field of cancer diagnostics, holding 2 patents that focus on innovative methods for detecting malignant tumors.

Latest Patents

Her latest patents include the "Epidermal Growth Factor Receptor Ectodomain" and "Method of Cancer Detection." These patents provide diagnostic and prognostic methods for detecting and quantifying elevated levels of the epidermal growth factor receptor (EGFr) in body fluids, particularly serum. The methods are designed for mammals carrying a malignant tumor burden. The patents disclose substantially pure compositions comprising EGFr ectodomain protein and fragments, along with test kits for performing the assays.

Career Highlights

Throughout her career, Susan has worked with prominent companies such as Chiron Diagnostics Corporation and Ciba Corning Diagnostics Corporation. Her work has significantly impacted the field of diagnostics, particularly in cancer detection.

Collaborations

Some of her notable coworkers include Roger P Walker and Patricia A McDonald. Their collaborative efforts have contributed to advancements in diagnostic methods.

Conclusion

Susan L Hammond's innovative work in cancer detection exemplifies her dedication to improving diagnostic methods for malignant tumors. Her contributions continue to influence the field and enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…